Arriving in the landscape of obesity therapy, retatrutide is a distinct method. Unlike many available medications, retatrutide works as a dual agonist, concurrently targeting both glucagon-like peptide-1 (GLP-1) and glucose-responsive insulinotropic substance (GIP) receptors. The dual stimulation encourages several helpful effects, like improved gl… Read More